NCI achieves the enrollment objective of thirty patients in the checkpoint inhibitor refractory arm of…
ROCKVILLE, Md., March 15, 2022 (GLOBE NEWSWIRE) — OpGen, Inc. (NASDAQ: OPGN) (“OpGen” or “the…
SAN DIEGO, March 15, 2022 (GLOBE NEWSWIRE) — Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated…
CAMBRIDGE, Mass., March 15, 2022 (GLOBE NEWSWIRE) — Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology…
LEXINGTON, Mass., March 15, 2022 (GLOBE NEWSWIRE) — iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the…
TORONTO, March 15, 2022 (GLOBE NEWSWIRE) — Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”) (TSX:…
Broadened strategic focus and expanded pipeline in immunology and inflammation following acquisition of rights to…
– Toripalimab plus chemotherapy met both primary endpoint of progression free survival and prespecified secondary…
REHOVOT, Israel, March 15, 2022 (GLOBE NEWSWIRE) — Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a…
GUANGZHOU, China, March 15, 2022 (GLOBE NEWSWIRE) — Burning Rock Biotech Limited (NASDAQ: BNR, the…
Data readouts from multiple clinical trials expected during the next 6 to 12 months Strong…
Revenues Grew 40% for the Fourth Quarter and 42% for Full Year 20212022 Guidance Reaffirmed…
On track for top-line data in April 2022 WARRINGTON, Pa., March 15, 2022 (GLOBE NEWSWIRE)…
DUBLIN, Ireland and FORT WASHINGTON, Pa., March 15, 2022 (GLOBE NEWSWIRE) — Nabriva Therapeutics plc…
On track to submit IND application for ENTR-601-44 targeting Duchenne muscular dystrophy in 2H 2022…
Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG,…
Completed enrollment in Phase 2b sickle cell disease and beta-thalassemia trials with tovinontrine (IMR-687); expect…
– Presented positive initial dose-escalation clinical data for SL-172154, including high target occupancy, dose-dependent immune…
LOS ANGELES, March 15, 2022 (GLOBE NEWSWIRE) — (NASDAQ: ENOB) — Enochian BioSciences, a company focused…
APEX, SUMMIT and PEAK bezuclastinib clinical trials actively enrolling patients APEX initial clinical data presentation…